Obtaining recombinant DNA
Recombinant DNA is an artificial combination of DNA pieces from different sources. It was first obtained in 1972–73 in the experiments of P. Berg, S. Cohen and H. Boyer. The steps: 1) obtain the needed gene from the donor organism – by cutting with a restriction enzyme, by making cDNA from mRNA with revertase, or, if its nucleotide sequence is known, by chemical synthesis; 2) choose a vector – usually a plasmid (or a virus or phage) that carries an antibiotic-resistance gene; 3) cut gene and vector with the same restriction enzyme and join them with ligase – a recombinant plasmid forms; 4) introduce it into a recipient cell (E. coli, yeast) – transformation; 5) selection – if antibiotic is added to the medium, only bacteria that took up the recombinant plasmid survive; 6) cloning – such cells multiply, the copies of the foreign gene multiply (gene cloning) and the gene makes protein (expression). Human insulin, growth hormone and interferon are made this way. Gene therapy, replacing a faulty gene with a healthy one, is being studied.
The main protein of the hepatitis B vaccine is made in yeast cells: the gene for the protein is put into a plasmid and then into yeast, and as the cells multiply they produce more protein. This gives the protein in large amounts without needing the virus itself.
A bioreactor operator monitors cell growth, a quality-control analyst checks product purity, and a regulatory officer reviews the documents.
Write one question you would ask a scientist who makes proteins in yeast, such as how they check that the product is pure.
“Recombinant builder”: groups cut paper plasmid and gene cards (an adult helps with scissors), join them in the right order and arrange the 6 steps.